The latest biopharma awards press releases and news
IMAPAC Applauds Thermo Fisher Scientific on Winning 3 Awards at the Asia Pacific Biologics CMO Excellence Awards and Asia Pacific Cell & Gene Therapy Excellence Awards 2023
Singapore, September 14, 2023 – IMAPAC, a leading event management company specializing in the biopharmaceutical industry, congratulates Thermo Fisher Scientific on receiving the “Best Biologics CMO in Australasia”, “Best Cell & Gene Therapy Supplier Award: AAV Vector Manufacturing”, and “Best Cell & Gene Therapy Supplier Award – Gene Editing”
Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics, and commercial manufacturing to customers through Patheon brand. With more than 60 locations around the world, Thermo Fisher provide integrated, end-to-end capabilities across all phases of development, including API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services, and commercial manufacturing, and packaging. Built on a reputation for scientific and technical excellence, the company provides pharma and biotech companies of all sizes instant access to a global network of facilities and experts across the Americas, Europe, Asia, and Australia.
Thermo Fisher offer integrated drug development and clinical services tailored to fit drug development journey through Patheon™ Quick to Care™ program. Patheon™ Quick to Clinic™ programs for large and small molecules help balance speed and risk during early development so clients can file their Investigational New Drug Application (IND) quickly and successfully. Digital innovations such as mysupply Platform and Pharma 4.0 enablement offer real-time data and a streamlined experience. Together with their customers, Thermo Fisher rapidly turning pharmaceutical possibilities into realities.
“Thermo Fisher Scientific is honored to be recognized by IMAPAC as the best biologics CDMO in Australasia,” stated Paul Jorjorian, vice president & general manager, biologics, Thermo Fisher Scientific. “This award reflects the trust our customers place in us as well as our ability to serve the needs of biopharma and biotech companies with speed and flexibility. We look forward to continuing to accelerate innovation and drive productivity for our customers globally so they can deliver therapies to patients in need.”
IMAPAC is a leading event management company specializing in the biopharmaceutical industry. With over 12 years of experience, IMAPAC has successfully organized more than 50 industry events, attracting over 15,000 participants from around the world. IMAPAC’s events are renowned for their high-quality content, prestigious speakers, and networking opportuniti
IMAPAC has successfully held the Asia-Pacific Bioprocessing Excellence Awards 2023, recognizing outstanding achievements and contributions in bioprocessing. The awards ceremony attracted over 80 participants from more than 40 biopharmaceutical companies across the Asia-Pacific region, with 53 categories such as Best Biomanufacturing Team and Best Emerging Biotech Company.
The Biopharma Logistics and Supply Chain Excellence Awards (BLSA) 2023 APAC recognized outstanding achievements in biologistics across Asia at their 2023 ceremony, held alongside the 7th BioLogistics World Asia event. The awards celebrate exceptional personnel, organizations, and technologies in the industry and aim to inspire future innovators.
The Biopharma R&D and Clinical Trials Awards (BRCTA) 2023 recognized exceptional Asian clinical trials leaders, organizations, and technologies over the past year. The awards include various categories such as Excellence Awards, Individual Awards, and Team Awards, identifying the best of the best in the industry.